started · updated
WHO issues first global guidelines for childhood obesity management
The World Health Organization (WHO) has issued its first global guidelines for managing obesity in children and adolescents. The organization emphasizes that the foundation of care should be structured lifestyle interventions, including healthy eating, physical activity, and behavioral support, rather than medical or surgical procedures.
For children up to age 9, the WHO advises against the use of weight-loss drugs, bariatric surgery, or weight-loss devices. For adolescents aged 10 to 19, pharmacological treatments are recommended only as a last resort after at least six months of supervised lifestyle interventions have failed to achieve desired results.
The guidelines arrive amid a global health crisis: the prevalence of obesity in children and adolescents aged 5-19 has quadrupled from 2% in 1990 to 8% in 2024, affecting an estimated 170 million young people. Of these, 70 million are aged 5-9 and 100 million are adolescents.
Clinical data highlights the potential of certain medications; for instance, the STEP TEENS study showed an average 18% BMI reduction in adolescents using semaglutide, while the STEP Young study indicated that 40.4% of children aged 6-11 treated with semaglutide and lifestyle changes no longer met obesity criteria after 68 weeks. However, the WHO notes that long-term effects of such drugs on the growth and mental health of developing children remain a subject of study.
Entities
Anvisa · Eli Lilly · Luz Maria De Regil · Novo Nordisk · World Health Organization
Claims
What the coverage asserts, and how many sources carry each claim.
- [DISPUTED] Weight-loss drugs, surgery, and devices are prohibited for children under the age of 10. www.ilcampanile.it · cangurunews.com.br · www.sheknows.com · dropsdejogos.uai.com.br
- [● 4 SOURCES] In 2024, 170 million children and adolescents aged 5-19 were living with obesity worldwide. www.ilcampanile.it · www.diariodesalud.com.do · www.sheknows.com · dropsdejogos.uai.com.br
- [○ 1 SOURCE] The STEP Young study showed 40.4% of children aged 6 to under 12 treated with semaglutide and lifestyle interventions stopped being classified as obese after 68 weeks. www.moneyreport.com.br
- [○ 1 SOURCE] The STEP TEENS clinical study showed an average 18% reduction in BMI for adolescents treated with semaglutide. www.moneyreport.com.br
- [● 4 SOURCES] The global obesity rate for children and adolescents aged 5-19 rose from 2% in 1990 to 8% in 2024. www.ilcampanile.it · www.diariodesalud.com.do · www.sheknows.com · dropsdejogos.uai.com.br
- [● 6 SOURCES] The WHO recommends structured care based on diet, physical activity, and behavioral support. www.ilcampanile.it · www.diariodesalud.com.do · cangurunews.com.br · www.farmacista33.it · www.sheknows.com · +1 more
- [● 7 SOURCES] The WHO released its first global guidelines for treating obesity in children and adolescents. www.ilcampanile.it · www.diariodesalud.com.do · cangurunews.com.br · www.farmacista33.it · www.moneyreport.com.br · +2 more
- [● 5 SOURCES] For adolescents aged 10 to 19, medication is recommended only as a last resort after lifestyle interventions fail for at least six months. www.ilcampanile.it · cangurunews.com.br · www.farmacista33.it · dropsdejogos.uai.com.br · www.sheknows.com